Neutralizing activity of antibodies to the V3 loop region of HIV-1 gp120 relative to their epitope fine specificity

被引:50
|
作者
Pantophlet, Ralph [1 ]
Wrin, Terri [3 ]
Cavacini, Lisa A. [4 ,5 ]
Robinson, James E. [6 ]
Burton, Dennis R. [1 ,2 ]
机构
[1] Scripps Res Inst, Dept Immunol & Microbial Sci, IMM2, La Jolla, CA 92037 USA
[2] Scripps Res Inst, Dept Mol Biol, La Jolla, CA 92037 USA
[3] Monogram Biosci, San Francisco, CA 94080 USA
[4] Beth Israel Deaconess Med Ctr, Dept Med, Div Hematol Oncol, Boston, MA 02115 USA
[5] Harvard Univ, Sch Med, Boston, MA 02115 USA
[6] Tulane Univ, Sch Med, Dept Pediat, New Orleans, LA 70112 USA
关键词
V3; antibodies; Cross-neutralization; accessibility; Epitope mapping; HIV vaccine design;
D O I
10.1016/j.virol.2008.08.032
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
The V3 loop of HIV-1 gp120 is considered occluded on many primary viruses. However, Virus sensitivity to neutralization by different V3 mAbs often varies, indicating that access to V3 is not restricted equally for all antibodies. Here, we have sought to gain a better understanding of these restrictions by determining the neutralizing activities of 7 V3 mAbs (19b, 39F, CO11, F2A3, F530, LA21, and LE311) against 15 subtype B primary isolates and relating these activities to the fine specificity of the mAbs. Not surprisingly, we found that most mAbs neutralized the same 2-3 viruses, with only mAb F530 able to neutralize 2 additional viruses not neutralized by the other mAbs. Epitope mapping revealed that positively-charged residues in or near the V3 stem are important for the binding of all the mAbs and that most mAbs seem to require the Pro residue that forms the GPGR beta hairpin turn in the V3 tip for binding. Based on the mapping, we determined that V3 sequence variation accounted for neutralization resistance of approximately half the viruses tested. Comparison of these results to those of select V3 mAbs with overall better neutralizing activities in the light of structural information illustrates how an antibody's mode of interaction with V3, driven by contact residue requirements, may restrict the antibody from accessing its epitope on different viruses. Based on the data we propose an angle of interaction with V3 that is less stringent on access for antibodies with cross-neutralizing activity compared to antibodies that neutralize relatively fewer viruses. (C) 2008 Elsevier Inc. All rights reserved.
引用
收藏
页码:251 / 260
页数:10
相关论文
共 50 条
  • [1] Focusing the immune response on the V3 loop, a neutralizing epitope of the HIV-1 gp120 envelope
    Zolla-Pazner, Susan
    Cohen, Sandra Sharpe
    Krachmarov, Chavdar
    Wang, Shixia
    Pinter, Abraham
    Lu, Shan
    VIROLOGY, 2008, 372 (02) : 233 - 246
  • [2] Model of the functioning of the V3 loop central epitope of HIV-1 gp120 in complex with antibodies
    Shchelkanov, MY
    Yaroslavtseva, NG
    Emel'yanov, AV
    Sakhuriya, IB
    Abelyan, AV
    Verevochkin, SV
    Kozlov, AP
    Karamov, EV
    MOLECULAR BIOLOGY, 1998, 32 (06) : 899 - 909
  • [3] Dual specificity of a human neutralizing monoclonal antibody, specific for the V3 loop of GP120 (HIV-1)
    Laisney, IL
    Strosberg, AD
    IMMUNOLOGY LETTERS, 1999, 67 (03) : 185 - 192
  • [4] Dual conformations for the HIV-1 gp120 V3 loop in complexes with different neutralizing Fabs
    Stanfield, RL
    Cabezas, E
    Satterthwait, AC
    Stura, EA
    Profy, AT
    Wilson, IA
    STRUCTURE, 1999, 7 (02) : 131 - 142
  • [5] REPERTOIRE OF NEUTRALIZING HUMAN MONOCLONAL-ANTIBODIES SPECIFIC FOR THE V3 DOMAIN OF HIV-1 GP120
    GORNY, MK
    XU, JY
    KARWOWSKA, S
    BUCHBINDER, A
    ZOLLAPAZNER, S
    JOURNAL OF IMMUNOLOGY, 1993, 150 (02): : 635 - 643
  • [6] V3 LOOP REGION OF THE HIV-1 GP120 ENVELOPE PROTEIN IS ESSENTIAL FOR VIRUS INFECTIVITY
    IVANOFF, LA
    DUBAY, JW
    MORRIS, JF
    ROBERTS, SJ
    GUTSHALL, L
    STERNBERG, EJ
    HUNTER, E
    MATTHEWS, TJ
    PETTEWAY, SR
    VIROLOGY, 1992, 187 (02) : 423 - 432
  • [7] GP120: Target for neutralizing HIV-1 antibodies
    Pantophlet, Ralph
    Burton, Dennis R.
    ANNUAL REVIEW OF IMMUNOLOGY, 2006, 24 : 739 - 769
  • [8] Role of gp120 V3 loop charge in HIV-1 coreceptor selectivity
    Lopez de Victoria, Aliana
    Kieslich, Chris A.
    Shin, David
    Tamamis, Phanourios
    Gonzalez-Rivera, Gloria
    Morikis, Dimitrios
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2012, 243
  • [9] Sequence variation and consensus sequence of V3 loop on HIV-1 gp120
    Tian, HJ
    Lan, CH
    Chen, YH
    IMMUNOLOGY LETTERS, 2002, 83 (03) : 231 - 233
  • [10] Characterization of a Large Panel of Rabbit Monoclonal Antibodies against HIV-1 gp120 and Isolation of Novel Neutralizing Antibodies against the V3 Loop
    Qin, Yali
    Banerjee, Saikat
    Agrawal, Aditi
    Shi, Heliang
    Banasik, Marisa
    Lin, Feng
    Rohl, Kari
    LaBranche, Celia
    Montefiori, David C.
    Cho, Michael W.
    PLOS ONE, 2015, 10 (06):